160 studies found for:    Open Studies | "Malaria"
Show Display Options
Rank Status Study
21 Recruiting Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria
Condition: Malaria
Intervention: Drug: Coartem
22 Recruiting A Comparison of Diagnostic Approaches for Malaria and Pneumonia
Conditions: Malaria;   Pneumonia
Intervention: Other: malaria or pneumonia diagnosis
23 Recruiting An Epidemiology Study of Malaria Transmission Intensity in Children in Sub-Saharan Africa
Condition: Malaria
Interventions: Procedure: Blood sampling;   Procedure: Assessment of body temperature
24 Unknown  Parasite-based Diagnosis for Malaria in Uganda: Feasibility and Cost-Effectiveness
Conditions: Fever;   Malaria
Intervention: Device: Field microscopy and Paracheck Pf®
25 Recruiting Providers' Compliance to Malaria Treatment
Condition: Malaria
Intervention: Other: SMS reminders
26 Recruiting Computerized Cognitive Rehabilitation in Children After Severe Malaria
Condition: Malaria
Intervention: Behavioral: Computerised cognitive rehabilitation training
27 Recruiting Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia
Condition: Plasmodium Vivax Malaria Without Complication
Interventions: Drug: Artemether-lumefantrine + Primaquine;   Drug: Chloroquine + Primaquine
28 Unknown  Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria
Condition: Uncomplicated Falciparum Malaria
Interventions: Drug: AM(FDC);   Drug: AM(LT);   Drug: AL;   Drug: DP;   Drug: AA(FDC)
29 Not yet recruiting Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya
Condition: Malaria
Interventions: Device: Spatial Repellent product with active ingredient;   Device: Active ingredient;   Device: Spatial Repellent product without active ingredient (SHIELD)
30 Recruiting Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia
Condition: Malaria
Interventions: Device: Spatial Repellent product with active ingredient (SHIELD);   Device: Active ingredient;   Device: Spatial Repellent product without active ingredient (SHIELD)
31 Not yet recruiting Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)
Condition: Malaria
Interventions: Device: Spatial Repellent product with active ingredient (SHIELD);   Device: Active Ingredient;   Device: Spatial Repellent product without active ingredient (SHIELD)
32 Not yet recruiting Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania
Condition: Malaria
Interventions: Device: Spatial Repellent product with active ingredient;   Device: Active ingredient;   Device: Spatial Repellent product without active ingredient (SHIELD)
33 Unknown  Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage)
Condition: Malaria
Interventions: Biological: Lyophilised PEBS synthetic protein (PfPEBS);   Other: Rehydragel™ HPA
34 Recruiting Optimal Fluid Management in Adult Severe Malaria
Conditions: Malaria;   Sepsis
Intervention:
35 Recruiting Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
Condition: Malaria
Intervention: Other: Artemether-lumefantrine
36 Recruiting Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study
Condition: Malaria
Interventions: Drug: ivermectin;   Drug: placebo;   Drug: dihydroartemisinin-piperaquine
37 Unknown  Plasmodium Resistance in A. Gambiae
Conditions: Malaria;   Plasmodium Falciparum Malaria
Intervention:
38 Unknown  Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
Condition: Malaria
Interventions: Biological: GMZ2 (malaria vaccine);   Biological: GMZ2 malaria vaccine;   Biological: Verorab vaccine
39 Recruiting Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria
Condition: Malaria
Interventions: Drug: Paracetamol;   Drug: No Paracetamol
40 Recruiting An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa
Condition: Malaria
Intervention: Procedure: Blood sampling

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years